Preventing Drug Abuse

Five Lessons from a National Collaboration to Promote Prescription Drug Safety

Providing access to safe and affordable medicines is the highest priority for our members and us. Last fall, AAM's Chip Davis was honored as a Champion for Drug-Free Kids by the Community Anti-Drug Coalitions of America (CADCA), an alliance of more than 5,000 community coalitions building safe, healthy and drug-free communities.

Opioid Tax Bills

It is critical that we combat the misuse and abuse of prescription medication while maintaining legitimate, uninterrupted access to medicine by patients in need. Generic drug manufacturers play a key role in producing affordable FDA-approved therapies and believe that patient safety is of the utmost importance. It is a public health imperative that patients take medicines as prescribed and adhere to the instructions of their health care providers.

Key Points:

Overview of the EverFi Prescription Drug Abuse Prevention Digital Course

Opioid abuse is now the number one cause of accidental deaths in the U.S. The Association for Accessible Medicines (AAM) is tackling this issue head on by empowering college students with the knowledge and skills they need to make safe and healthy decisions about prescription medications. In partnership with education technology leader EverFi, AAM has developed an innovative digital learning course that uses an evidence-based approach to encourage safe and responsible decision-making.

EverFi Opioid Abuse Prevention Education Program — underwritten by AAM

The abuse of prescription opioids and stimulants is a serious risk on today’s college campuses. That’s why the Association for Accessible Medicines (AAM) is offering an evidence-based curriculum to help prevent abuse--and it’s free to any college in America. Created with EVERFI, a leader in digital learning and prevention education solutions, including AlcoholEdu, the curriculum equips students with the knowledge and skills they need to help make healthy choices for themselves and their classmates. Learn how to bring this important program to college students in your state or district.

2017 AAM Annual Report

2017 Was Epic

The landscape around us looks much different today than it did just one year ago. As our industry changes within the evolving pharmaceutical ecosystem, we must speak with one voice to drive home the message that a robust generic drug and biosimilars marketplace is necessary to sustain affordable health care.

Subscribe to Preventing Drug Abuse

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.